Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis

Journal of Neurochemistry

Volumn 83, Issue 2, 2002, Pages 412-420

  Delobel, Patrice ^a   Flament, Stéphane ^b,c   Hamdane, Malika ^a   Mailliot, Christel ^a   Sambo, Anne Véronique ^a   Bégard, Séverine ^a   Sergeant, Nicolas ^a   Delacourte, André ^a   Vilain, Jean Pierre ^b   Buée, Luc ^a  

^a INSERM   (France)

^b UNIV LILLE   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Alzheimer's disease; Microtubule associated Tau proteins; Mitosis; Oocyte maturation; Phosphorylation

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROPHORETIC MOBILITY; GENE OVEREXPRESSION; IMMUNOREACTIVITY; MEIOSIS; MITOSIS; NONHUMAN; OOCYTE; OOCYTE MATURATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; XENOPUS LAEVIS;

ALZHEIMER DISEASE; ANIMALS; EPITOPES; HUMANS; MEIOSIS; MICROINJECTIONS; MITOSIS; NEUROBLASTOMA; OOCYTES; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; TAU PROTEINS; TRANSFECTION; XENOPUS;

ANIMALIA; XENOPUS LAEVIS;

EID: 18644369888     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01143.x     Document Type: Article

References (37)

1. Arendt T., Holzer M., Stobe A., Gartner U., Luth H. J., Bruckner M. K. and Ueberham U. (2000) Activated mitogenic signaling induces a process of dedifferentiation in Alzheimer's disease that eventually results in cell death. Ann. NY Acad. Sci. 920, 249-255.
2. Azzi L., Meijer L., Ostvold A. C., Lew J. and Wang J. H. (1994) Purificafion of a 15-kDa cdk4- and cdk5-binding protein. J. Biol. Chem. 269, 13279-13288.
3. Bodart J. F., Bechard D., Bertout M., Gannon J., Rousseau A., Vilain J. P. and Flament S. (1999) Activation of Xenopus eggs by the kinase inhibitor 6-DMAP suggests a differential regulation of cyclin B and p39 (mos) proteolysis. Exp. Cell Res. 253, 413-421.
4. Borgne A. and Meijer L. (1996) Sequential dephosphorylation of p34 (cdc2) on Thr-14 and Tyr-15 at the prophase/metaphase transition. J. Biol. Chem. 271, 27847-27854.
5. Buée L., Bussière T., Buée-Scherrer V., Delacourte A. and Hof P. R. (2000) Tau protein isoforms, phosphorylation and role in neuro-degenerative disorders. Brain Res. Rev. 33, 95-130.
6. Buée-Scherrer V. and Goedert M. (2002) Phosphorylation of microtubule-associated protein Tau by stress-activated protein kinases in intact cells. FEBS Lett. 515, 151-154.
7. Buée-Scherrer V., Condamines O., Mourton-Gilles C., Jakes R., Goedert M., Pau B. and Delacourte A. (1996) AD 2, a phosphorylation-dependent monoclonal antibody directed against Tau proteins found in Alzheimer's disease. Mol. Brain Res. 39, 79-88.
8. Bussière T., Hof P. R., Mailliot C., Brown C. D., Caillet-Boudin M. L., Perl D. P., Buée L. and Delacourte A. (1999) Phosphorylated serine422 on Tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration. Acta Neuropathol. 97, 221-230.
9. Delobel P., Flament S., Hamdane M., Jakes R., Rousseau A., Delacourte A., Goedert M. and Buée L. (2002a) Functional characterization of FTDP-17 tau gene mutations through their effects on Xenopus oocyte maturation. J. Biol. Chem. 277, 9199-9205.
10. Delobel P., Flament S., Hamdane M., Delacourte A., Vilain J. P. and Buée L. (2002b) Modelling Alzheimer-specific Tau phosphorylation independently of GSK3β and pKA kinase activities. FEBS Lett. 516, 151-155.
11. Ding X. L., Husseman J., Tomashevski A., Nochlin D., Jin L. W. and Vincent I. (2000) The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease. Am. J. Pathol. 157, 1983-1990.
12. Flament S., Browaeys E., Rodeau J. L., Bertout M. and Vilain J. P. (1996) Xenopus oocyte maturation: cytoplasm alkalization is involved in germinal vesicle migration. Int. J. Dev. Biol. 40, 471-476.
13. Goedert M., Jakes R., Crowther R. A., Cohen P., Vanmechelen E., Vandermeeren M. and Cras P. (1994) Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in Tau protein. Biochem. J. 301, 871-877.
14. Goedert M., Jakes R. and Vanmechelen E. (1995) Monoclonal antibody AT8 recognises Tau protein phosphorylated at both serine 202 and threonine 205. Neurosci. Lett. 189, 167-169.
15. Harris P. L., Zhu X., Pamies C., Rottkamp C. A., Ghanbari H. A., McShea A., Feng Y., Ferris D. K. and Smith M. A. (2000) Neuronal polo-like kinase in Alzheimer's disease indicates cell cycle changes. Neurobiol. Aging 21, 837-841.
16. Hasegawa M., Jakes R., Crowther R. A., Lee V. M., Ihara Y. and Goedert M. (1996) Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against Tau protein. FEBS Lett. 384, 25-30.
17. Husseman J. W., Nochlin D. and Vincent I. (2000) Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases. Neurobiol. Aging 21, 815-828.
18. Illenberger S., Zheng-Fischhofer Q., Preuss U., Stamer K., Baumann K., Trinczek B., Biemat J., Godemann R., Mandelkow E. M. and Mandelkow E. (1998) The endogenous and cell cycle-dependent phosphorylation of Tau protein in living cells: implications for Alzheimer's disease. Mol. Biol. Cell 9, 1495-1512.
19. Karaiskou A., Jessus C., Brassac T. and Ozon R. (1999) Phosphatase 2A and polo kinase, two antagonistic regulators of cdc25 activation and MPF auto-amplification. J. Cell Sci. 112, 3747-3756.
20. Ksiezak-Reding H., He D., Gordon-Krajcer W., Kress Y., Lee S. and Dickson D. W. (2000) Induction of Alzheimer-specific Tau epitope AT100 in apoptotic human fetal astrocytes. Cell Motil. Cytoskeleton 47, 236-252.
21. Lu P. J., Wulf G., Zhou X. Z., Davies P. and Lu K. P. (1999) The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated Tau protein. Nature 399, 784-788.
22. Mailliot C., Bussière T., Caillet-Boudin M. L., Delacourte A. and Buée L. (1998) Alzheimer-specific epitope of AT100 in transfected cell lines with Tau: toward an efficient cell model of Tau abnormal phosphorylation. Neurosci. Lett. 255, 13-16.
23. Mailliot C., Bussière T., Hamdane M., Sergeant N., Caillet-Boudin M. L., Delacourte A. and Buée L. (2000) Pathological Tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities. Ann. NY Acad. Sci. 920, 107-114.
24. Masui Y. (2001) From oocyte maturation to the in vitro cell cycle: the history of discoveries of maturation-promoting factor (MPF) and cytostatic factor (CSF). Differentiation 69, 1-17.
25. Peter M., Nakagawa J., Doree M., Labbe J. C. and Nigg E. A. (1990) Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase. Cell 60, 791-801.
26. Pope W. B., Lambert M. P., Leypold B., Seupaul R., Sletten L., Krafft G. and Klein W. L. (1994) Microtubule-associated protein Tau is hyperphosphorylated during mitosis in the human neuroblastoma cell line SH-SY5Y. Exp. Neurol. 126, 185-194.
27. Preuss U. and Mandelkow E. M. (1998) Mitotic phosphorylation of Tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease. Eur. J. Cell Biol. 76, 176-184.
28. Rime H., Huchon D., De Smedt V., Thibier C., Galaktionov K., Jessus C. and Ozon R. (1994) Microinjection of Cdc25 protein phosphatase into Xenopus prophase oocyte activates MPF and arrests meiosis at metaphase I. Biol. Cell 82, 11-22.
29. Roder H. M., Fracasso R. P., Hoffman F. J., Witowsky J. A., Davis G. and Pellegrino C. B. (1997) Phosphorylation-dependent monoclonal Tau antibodies do not reliably report phosphorylation by extracellular signal-regulated kinase 2 at specific sites. J. Biol. Chem. 272, 4509-4515.
30. Sergeant N., Sablonniere B., Schraen-Maschke S., Ghestem A., Maurage C. A., Wattez A., Vermersch P. and Delacourte A. (2001) Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum. Mol. Genet. 10, 2143-2155.
31. Shtil A. A., Mandlekar S., Yu R., Walter R. J., Hagen K., Tan T. H., Roninson I. B. and Kong A. N. (1999) Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells. Oncogene 18, 377-384.
32. Szendrei G. I., Lee V. M. and Otvos L. Jr (1993) Recognition of the minimal epitope of monoclonal antibody Tau-1 depends upon the presence of a phosphate group but not its location. J. Neurosci. Res. 34, 243-249.
33. Vincent I., Jicha G., Rosado M. and Dickson D. W. (1997) Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J. Neurosci. 17, 3588-3598.
34. Vincent I., Rosado M. and Davies P. (1996) Mitotic mechanisms in Alzheimer's disease? J. Cell Biol. 132, 413-425.
35. Vincent I., Zheng J. H., Dickson D. W., Kress Y. and Davies P. (1998) Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease. Neurobiol. Aging 19, 287-296.
36. Wang T. H., Wang H. S., Ichijo H., Giannakakou P., Foster J. S., Fojo T. and Wimalasena J. (1998) Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J. Biol. Chem. 273, 4928-4936.
37. Zheng-Fischhöfer Q., Biemat J., Mandelkow E. M., Illenberger S., Godemann R. and Mandelkow E. (1998) Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur J. Biochem. 252, 542-552.